Giaddui Tawfik, Geng Huaizhi, Chen Quan, Linnemann Nancy, Radden Marsha, Lee Nancy Y, Xia Ping, Xiao Ying
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Radiation Oncology, Temple University Hospital, Philadelphia, Pennsylvania.
Adv Radiat Oncol. 2020 May 22;5(6):1342-1349. doi: 10.1016/j.adro.2020.05.005. eCollection 2020 Nov-Dec.
This study aimed to investigate whether a disease site-specific, multi-institutional knowledge based-planning (KBP) model can improve the quality of intensity modulated radiation therapy treatment planning for patients enrolled in the head and neck NRG-HN001clinical trial and to establish a threshold of improvements of treatment plans submitted to the clinical trial.
Fifty treatment plans for patients enrolled in the NRG-HN001 clinical trial were used to build a KBP model; the model was then used to reoptimize 50 other plans. We compared the dosimetric parameters of the submitted and KBP reoptimized plans. We compared differences between KBP and submitted plans for single- and multi-institutional treatment plans.
Mean values for the dose received by 95% of the planning target volume (PTV_6996) and for the maximum dose (D0.03cc) of PTV_6996 were 0.5 Gy and 2.1 Gy higher in KBP plans than in the submitted plans, respectively. Mean values for D0.03cc to the brain stem, spinal cord, optic nerve_R, optic nerve_L, and chiasm were 2.5 Gy, 1.9 Gy, 6.4 Gy, 6.6 Gy, and 5.7 Gy lower in the KBP plans than in the submitted plans. Mean values for D to parotid_R and parotid_L glands were 2.2 Gy and 3.8 Gy lower in KBP plans, respectively. In 33 out of 50 KBP plans, we observed improvements in sparing of at least 7 organs at risk (OARs) (brain stem, spinal cord, optic nerves (R & L), chiasm, and parotid glands [R & L]). A threshold of improvement of OARs sparing of 5% of the prescription dose was established for providing the quality assurance results back to the treating institution.
A disease site-specific, multi-institutional, clinical trial-based KBP model improved sparing of OARs in a large number of reoptimized plans submitted to the NRG-HN001 clinical trial, and the model is being used as an offline quality assurance tool
本研究旨在调查一种针对疾病部位的、多机构的基于知识的计划(KBP)模型是否能够提高参加头颈部NRG-HN001临床试验患者的调强放射治疗计划质量,并确定提交至该临床试验的治疗计划的改进阈值。
利用NRG-HN001临床试验中50例患者的治疗计划构建KBP模型;然后使用该模型对另外50个计划进行重新优化。我们比较了提交的计划和KBP重新优化计划的剂量学参数。我们比较了KBP计划与单机构和多机构治疗计划的提交计划之间的差异。
在KBP计划中,95%计划靶体积(PTV_6996)所接受的剂量平均值和PTV_6996的最大剂量(D0.03cc)分别比提交的计划高0.5 Gy和2.1 Gy。KBP计划中脑干、脊髓、右侧视神经、左侧视神经和视交叉的D0.03cc平均值分别比提交的计划低2.5 Gy、1.9 Gy、6.4 Gy、6.6 Gy和5.7 Gy。KBP计划中右侧腮腺和左侧腮腺的D平均值分别低2.2 Gy和3.8 Gy。在50个KBP计划中的33个中,我们观察到至少7个危及器官(OARs)(脑干、脊髓、视神经(右侧和左侧)、视交叉和腮腺[右侧和左侧])的 sparing 有改善。为了将质量保证结果反馈给治疗机构,建立了OARs sparing改善5%处方剂量的阈值。
一种针对疾病部位的、多机构的、基于临床试验的KBP模型在提交至NRG-HN001临床试验的大量重新优化计划中改善了OARs的 sparing,并且该模型正被用作离线质量保证工具